메뉴 건너뛰기




Volumn 12, Issue , 2012, Pages

Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls

Author keywords

Case control study; H1N1; Hospitalization; Influenza; Risk factors; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

EID: 84861582340     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-127     Document Type: Article
Times cited : (17)

References (62)
  • 1
    • 67849107915 scopus 로고    scopus 로고
    • WHO, Geneva, . 2009. 21-9-2009
    • Chan M. World now at the start of 2009 influenza pandemic 2009, WHO, Geneva, http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/index.html. 2009. 21-9-2009.
    • (2009) World now at the start of 2009 influenza pandemic
    • Chan, M.1
  • 3
    • 77953049187 scopus 로고    scopus 로고
    • The first wave of pandemic influenza (H1N1) 2009 in Germany: from initiation to acceleration
    • 10.1186/1471-2334-10-155, 2902478, 20525408, RKI Working Group
    • Poggensee G, Gilsdorf A, Buda S, Eckmanns T, Claus H, Altmann D, Krause G, Haas W, . RKI Working Group The first wave of pandemic influenza (H1N1) 2009 in Germany: from initiation to acceleration. BMC Infect Dis 2010, 10:155. 10.1186/1471-2334-10-155, 2902478, 20525408, RKI Working Group.
    • (2010) BMC Infect Dis , vol.10 , pp. 155
    • Poggensee, G.1    Gilsdorf, A.2    Buda, S.3    Eckmanns, T.4    Claus, H.5    Altmann, D.6    Krause, G.7    Haas, W.8
  • 4
    • 75249101993 scopus 로고    scopus 로고
    • Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial
    • 10.1016/j.vaccine.2009.12.014, 20034605
    • Roman F, Vaman T, Gerlach B, Markendorf A, Gillard P, Devaster JM. Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial. Vaccine 2010, 28:1740-1745. 10.1016/j.vaccine.2009.12.014, 20034605.
    • (2010) Vaccine , vol.28 , pp. 1740-1745
    • Roman, F.1    Vaman, T.2    Gerlach, B.3    Markendorf, A.4    Gillard, P.5    Devaster, J.M.6
  • 5
    • 77955937857 scopus 로고    scopus 로고
    • AS03A-adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age
    • 10.1086/655830, 20687838
    • Roman F, Vaman T, Kafeja F, Hanon E, Van Damme P. AS03A-adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age. Clin Infect Dis 2010, 51:668-677. 10.1086/655830, 20687838.
    • (2010) Clin Infect Dis , vol.51 , pp. 668-677
    • Roman, F.1    Vaman, T.2    Kafeja, F.3    Hanon, E.4    Van Damme, P.5
  • 6
    • 71549172015 scopus 로고    scopus 로고
    • Working group pandemic influenza A(H1N1)v: influenza A(H1N1)v in Germany: the first 10,000 cases
    • Gilsdorf A, Poggensee G. Working group pandemic influenza A(H1N1)v: influenza A(H1N1)v in Germany: the first 10,000 cases. Euro Surveill 2009, 14:1-4.
    • (2009) Euro Surveill , vol.14 , pp. 1-4
    • Gilsdorf, A.1    Poggensee, G.2
  • 7
    • 79955685941 scopus 로고    scopus 로고
    • Monitoring pandemic influenza A(H1N1) vaccination coverage in Germany 2009/10 - results from thirteen consecutive cross-sectional surveys
    • 10.1016/j.vaccine.2011.03.069, 21463683
    • Walter D, Heiden M, Reiter S, Krause G, Wichmann O. Monitoring pandemic influenza A(H1N1) vaccination coverage in Germany 2009/10 - results from thirteen consecutive cross-sectional surveys. Vaccine 2011, 29:4008-4012. 10.1016/j.vaccine.2011.03.069, 21463683.
    • (2011) Vaccine , vol.29 , pp. 4008-4012
    • Walter, D.1    Heiden, M.2    Reiter, S.3    Krause, G.4    Wichmann, O.5
  • 11
    • 84865284063 scopus 로고    scopus 로고
    • Telefonische Erhebung zur Impfung gegen die pandemische Influenza (H1N1) 2009 [Telephone survey regarding vaccination against pandemic influenza (H1N1) 2009]
    • Koch-Institut R. Telefonische Erhebung zur Impfung gegen die pandemische Influenza (H1N1) 2009 [Telephone survey regarding vaccination against pandemic influenza (H1N1) 2009]. Epidemiol Bull 2010, 13:114-115.
    • (2010) Epidemiol Bull , vol.13 , pp. 114-115
    • Koch-Institut, R.1
  • 12
    • 77954622497 scopus 로고    scopus 로고
    • Diagnostic approach for the differentiation of the pandemic influenza A(H1N1)v virus from recent human influenza viruses by real-time PCR
    • 10.1371/journal.pone.0009966, 2848602, 20376359
    • Schulze M, Nitsche A, Schweiger B, Biere B. Diagnostic approach for the differentiation of the pandemic influenza A(H1N1)v virus from recent human influenza viruses by real-time PCR. PLoS One 2010, 5:e9966. 10.1371/journal.pone.0009966, 2848602, 20376359.
    • (2010) PLoS One , vol.5
    • Schulze, M.1    Nitsche, A.2    Schweiger, B.3    Biere, B.4
  • 13
    • 77950514593 scopus 로고    scopus 로고
    • Differentiation of influenza B virus lineages yamagata and victoria by real-time PCR
    • 10.1128/JCM.02116-09, 2849545, 20107085
    • Biere B, Bauer B, Schweiger B. Differentiation of influenza B virus lineages yamagata and victoria by real-time PCR. J Clin Microbiol 2010, 48:1425-1427. 10.1128/JCM.02116-09, 2849545, 20107085.
    • (2010) J Clin Microbiol , vol.48 , pp. 1425-1427
    • Biere, B.1    Bauer, B.2    Schweiger, B.3
  • 14
    • 0033041241 scopus 로고    scopus 로고
    • Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays
    • 88628, 10074505
    • Rowe T, Abernathy RA, Hu-Primmer J, Thompson WW, Lu X, Lim W, Fukuda K, Cox NJ, Katz JM. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999, 37:937-943. 88628, 10074505.
    • (1999) J Clin Microbiol , vol.37 , pp. 937-943
    • Rowe, T.1    Abernathy, R.A.2    Hu-Primmer, J.3    Thompson, W.W.4    Lu, X.5    Lim, W.6    Fukuda, K.7    Cox, N.J.8    Katz, J.M.9
  • 21
    • 77958191681 scopus 로고    scopus 로고
    • Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study
    • 10.1016/j.vaccine.2010.09.042, 20875486
    • Puig-Barberà J, Arnedo-Pena A, Pardo-Serrano F, Tirado-Balaguer MD, Pérez-Vilar S, Silvestre-Silvestre E, Calvo-Mas C, Safont-Adsuara L, Ruiz-García M. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study. Vaccine 2010, 28:7460-7467. 10.1016/j.vaccine.2010.09.042, 20875486.
    • (2010) Vaccine , vol.28 , pp. 7460-7467
    • Puig-Barberà, J.1    Arnedo-Pena, A.2    Pardo-Serrano, F.3    Tirado-Balaguer, M.D.4    Pérez-Vilar, S.5    Silvestre-Silvestre, E.6    Calvo-Mas, C.7    Safont-Adsuara, L.8    Ruiz-García, M.9
  • 22
    • 78751704276 scopus 로고    scopus 로고
    • Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial
    • 10.1016/S1473-3099(10)70296-6, 21168369
    • Nicholson KG, Abrams KR, Batham S, Clark TW, Hoschler K, Lim WS, Medina MJ, Nguyen-Van-Tam JS, Read RC, Warren FC, et al. Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial. Lancet Infect Dis 2011, 11:91-101. 10.1016/S1473-3099(10)70296-6, 21168369.
    • (2011) Lancet Infect Dis , vol.11 , pp. 91-101
    • Nicholson, K.G.1    Abrams, K.R.2    Batham, S.3    Clark, T.W.4    Hoschler, K.5    Lim, W.S.6    Medina, M.J.7    Nguyen-Van-Tam, J.S.8    Read, R.C.9    Warren, F.C.10
  • 23
    • 78951479246 scopus 로고    scopus 로고
    • Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010
    • Available online:
    • Hardelid P, Fleming D, McMenamin J, Andrews N, Robertson C, Sebastianpillai P, Ellis J, Carman W, Wreghitt T, Watson J, et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill 2011, 16(2):pii=19763. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19763.
    • (2011) Euro Surveill , vol.16 , Issue.2
    • Hardelid, P.1    Fleming, D.2    McMenamin, J.3    Andrews, N.4    Robertson, C.5    Sebastianpillai, P.6    Ellis, J.7    Carman, W.8    Wreghitt, T.9    Watson, J.10
  • 25
    • 79951650357 scopus 로고    scopus 로고
    • Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of influenza monitoring vaccine effectiveness in Europe (I-MOVE) multicentre case-control study
    • 10.1371/journal.pmed.1000388, 3019108, 21379316
    • Valenciano M, Kissling E, Cohen JM, Oroszi B, Barret AS, Rizzo C, Nunes B, Pitigoi D, Larrauri Cámara A, Mosnier A, et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of influenza monitoring vaccine effectiveness in Europe (I-MOVE) multicentre case-control study. PLoS Med 2011, 8:e1000388. 10.1371/journal.pmed.1000388, 3019108, 21379316.
    • (2011) PLoS Med , vol.8
    • Valenciano, M.1    Kissling, E.2    Cohen, J.M.3    Oroszi, B.4    Barret, A.S.5    Rizzo, C.6    Nunes, B.7    Pitigoi, D.8    Larrauri CÃmara, A.9    Mosnier, A.10
  • 26
    • 77955167340 scopus 로고    scopus 로고
    • Vaccine effectiveness in pandemic influenza - primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine
    • Simpson CR, Ritchie LD, Robertson C, Sheikh A, McMenamin J. Vaccine effectiveness in pandemic influenza - primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine. Health Technol Assess 2010, 14:313-346.
    • (2010) Health Technol Assess , vol.14 , pp. 313-346
    • Simpson, C.R.1    Ritchie, L.D.2    Robertson, C.3    Sheikh, A.4    McMenamin, J.5
  • 27
    • 77952313958 scopus 로고    scopus 로고
    • Seasonal influenza risk in hospital healthcare workers is more strongly associated with household than occupational exposures: results from a prospective cohort study in Berlin, Germany, 2006/07
    • 10.1186/1471-2334-10-8, 2836320, 20067628
    • Williams C, Schweiger B, Diner G, Gerlach F, Haaman F, Krause G, Nienhaus A, Buchholz U. Seasonal influenza risk in hospital healthcare workers is more strongly associated with household than occupational exposures: results from a prospective cohort study in Berlin, Germany, 2006/07. BMC Infect Dis 2010, 10:8. 10.1186/1471-2334-10-8, 2836320, 20067628.
    • (2010) BMC Infect Dis , vol.10 , pp. 8
    • Williams, C.1    Schweiger, B.2    Diner, G.3    Gerlach, F.4    Haaman, F.5    Krause, G.6    Nienhaus, A.7    Buchholz, U.8
  • 28
    • 84858998158 scopus 로고    scopus 로고
    • Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10
    • Emborg H-D, Krause TG, Hviid A, Simonsen J, Molbak K. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10. BMJ 2012, 344:d7901.
    • (2012) BMJ , vol.344
    • Emborg, H.-D.1    Krause, T.G.2    Hviid, A.3    Simonsen, J.4    Molbak, K.5
  • 29
    • 79952060021 scopus 로고    scopus 로고
    • Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009
    • 10.1136/bmj.c7297, 3033439, 21292718
    • Skowronski DM, Janjua NZ, De Serres G, Hottes TS, Dickinson JA, Crowcroft N, Kwindt TL, Tang P, Charest H, Fonseca K, et al. Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. BMJ 2011, 342:c7297. 10.1136/bmj.c7297, 3033439, 21292718.
    • (2011) BMJ , vol.342
    • Skowronski, D.M.1    Janjua, N.Z.2    De Serres, G.3    Hottes, T.S.4    Dickinson, J.A.5    Crowcroft, N.6    Kwindt, T.L.7    Tang, P.8    Charest, H.9    Fonseca, K.10
  • 30
    • 79851499071 scopus 로고    scopus 로고
    • Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England
    • 10.1093/infdis/jiq014, 3086445, 21148494
    • Andrews N, Waight P, Yung CF, Miller E. Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England. J Infect Dis 2011, 203:32-39. 10.1093/infdis/jiq014, 3086445, 21148494.
    • (2011) J Infect Dis , vol.203 , pp. 32-39
    • Andrews, N.1    Waight, P.2    Yung, C.F.3    Miller, E.4
  • 31
    • 79955406980 scopus 로고    scopus 로고
    • Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza a(H1N1)v in stockholm county, Sweden
    • 10.1093/cid/cir182, 21507917
    • Ortqvist A, Berggren I, Insulander M, de Jong B, Svenungsson B. Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza a(H1N1)v in stockholm county, Sweden. Clin Infect Dis 2011, 52:1203-1211. 10.1093/cid/cir182, 21507917.
    • (2011) Clin Infect Dis , vol.52 , pp. 1203-1211
    • Ortqvist, A.1    Berggren, I.2    Insulander, M.3    de Jong, B.4    Svenungsson, B.5
  • 32
    • 79960746861 scopus 로고    scopus 로고
    • Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study
    • 10.1016/j.vaccine.2011.06.063, 21723358
    • Castilla J, Morán J, Martinez-Artola V, Fernández-Alonso M, Guevara M, Cenoz MG, Reina G, Alvarez N, Arriazu M, Elía F, et al. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study. Vaccine 2011, 29:5919-5924. 10.1016/j.vaccine.2011.06.063, 21723358.
    • (2011) Vaccine , vol.29 , pp. 5919-5924
    • Castilla, J.1    Morán, J.2    Martinez-Artola, V.3    Fernández-Alonso, M.4    Guevara, M.5    Cenoz, M.G.6    Reina, G.7    Alvarez, N.8    Arriazu, M.9    Elía, F.10
  • 33
    • 77952924289 scopus 로고    scopus 로고
    • Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients
    • 10.1097/QAD.0b013e3283398da1, 20559034
    • Bickel M, Wieters I, Khaykin P, Nisius G, Haberl A, Stephan C, Von HN, Herrmann E, Doerr HW, Brodt HR, et al. Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients. AIDS 2010, 24:F31-F35. 10.1097/QAD.0b013e3283398da1, 20559034.
    • (2010) AIDS , vol.24
    • Bickel, M.1    Wieters, I.2    Khaykin, P.3    Nisius, G.4    Haberl, A.5    Stephan, C.6    Von, H.N.7    Herrmann, E.8    Doerr, H.W.9    Brodt, H.R.10
  • 34
    • 79151472358 scopus 로고    scopus 로고
    • Immunogenicity and tolerability of an inactivated and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patients
    • 10.1016/j.vaccine.2010.12.023, 21185423
    • Tremblay CL, Rouleau D, Fortin C, Toma E, Sylla M, Cyr L, Cote S, Baz M, Sampalis J, Trautman L, et al. Immunogenicity and tolerability of an inactivated and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patients. Vaccine 2011, 29:1359-1363. 10.1016/j.vaccine.2010.12.023, 21185423.
    • (2011) Vaccine , vol.29 , pp. 1359-1363
    • Tremblay, C.L.1    Rouleau, D.2    Fortin, C.3    Toma, E.4    Sylla, M.5    Cyr, L.6    Cote, S.7    Baz, M.8    Sampalis, J.9    Trautman, L.10
  • 35
    • 84873096662 scopus 로고    scopus 로고
    • Repräsentative telefonische Erhebung zur Impfung gegen die pandemische Influenza (H1N1) 2009. Ergebnisse aus Befragungen bis April 2010 [Representative telephone survey on vaccination against pandemic influenza (H1N1) 2009. Results to April 2010]
    • Robert Koch-Institut
    • Robert Koch-Institut Repräsentative telefonische Erhebung zur Impfung gegen die pandemische Influenza (H1N1) 2009. Ergebnisse aus Befragungen bis April 2010 [Representative telephone survey on vaccination against pandemic influenza (H1N1) 2009. Results to April 2010]. Epidemiol Bull 2010, 25:237-238. Robert Koch-Institut.
    • (2010) Epidemiol Bull , vol.25 , pp. 237-238
  • 36
    • 34249325099 scopus 로고    scopus 로고
    • Validity of self-reported influenza and pneumococcal vaccination status among a cohort of hospitalized elderly inpatients
    • 10.1016/j.vaccine.2007.04.015, 17499402
    • Skull SA, Andrews RM, Byrnes GB, Kelly HA, Nolan TM, Brown GV, Campbell DA. Validity of self-reported influenza and pneumococcal vaccination status among a cohort of hospitalized elderly inpatients. Vaccine 2007, 25:4775-4783. 10.1016/j.vaccine.2007.04.015, 17499402.
    • (2007) Vaccine , vol.25 , pp. 4775-4783
    • Skull, S.A.1    Andrews, R.M.2    Byrnes, G.B.3    Kelly, H.A.4    Nolan, T.M.5    Brown, G.V.6    Campbell, D.A.7
  • 37
    • 17144398838 scopus 로고    scopus 로고
    • Compared to what? Finding controls for case-control studies
    • 10.1016/S0140-6736(05)66379-9, 15836892
    • Grimes DA, Schulz KF. Compared to what? Finding controls for case-control studies. Lancet 2005, 365:1429-1433. 10.1016/S0140-6736(05)66379-9, 15836892.
    • (2005) Lancet , vol.365 , pp. 1429-1433
    • Grimes, D.A.1    Schulz, K.F.2
  • 40
    • 77958179002 scopus 로고    scopus 로고
    • Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks
    • 10.1016/j.vaccine.2010.09.010, 20851086
    • Valenciano M, Kissling E, Ciancio BC, Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine 2010, 28:7381-7388. 10.1016/j.vaccine.2010.09.010, 20851086.
    • (2010) Vaccine , vol.28 , pp. 7381-7388
    • Valenciano, M.1    Kissling, E.2    Ciancio, B.C.3    Moren, A.4
  • 41
    • 34547843673 scopus 로고    scopus 로고
    • Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness
    • 10.1093/ije/dym021, 17403908
    • Orenstein EW, De Serres G, Haber MJ, Shay DK, Bridges CB, Gargiullo P, Orenstein WA. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007, 36:623-631. 10.1093/ije/dym021, 17403908.
    • (2007) Int J Epidemiol , vol.36 , pp. 623-631
    • Orenstein, E.W.1    De Serres, G.2    Haber, M.J.3    Shay, D.K.4    Bridges, C.B.5    Gargiullo, P.6    Orenstein, W.A.7
  • 42
    • 77951745708 scopus 로고    scopus 로고
    • Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada
    • 10.1371/journal.pmed.1000258, 2850386, 20386731
    • Skowronski DM, De SG, Crowcroft NS, Janjua NZ, Boulianne N, Hottes TS, Rosella LC, Dickinson JA, Gilca R, Sethi P, et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med 2010, 7:e1000258. 10.1371/journal.pmed.1000258, 2850386, 20386731.
    • (2010) PLoS Med , vol.7
    • Skowronski, D.M.1    De, S.G.2    Crowcroft, N.S.3    Janjua, N.Z.4    Boulianne, N.5    Hottes, T.S.6    Rosella, L.C.7    Dickinson, J.A.8    Gilca, R.9    Sethi, P.10
  • 43
    • 77958617529 scopus 로고    scopus 로고
    • Seasonal influenza vaccine and increased risk of pandemic A/H1N1-related illness: first detection of the association in British Columbia, Canada
    • 10.1086/656586, 20887210
    • Janjua NZ, Skowronski DM, Hottes TS, Osei W, Adams E, Petric M, Sabaiduc S, Chan T, Mak A, Lem M, et al. Seasonal influenza vaccine and increased risk of pandemic A/H1N1-related illness: first detection of the association in British Columbia, Canada. Clin Infect Dis 2010, 51:1017-1027. 10.1086/656586, 20887210.
    • (2010) Clin Infect Dis , vol.51 , pp. 1017-1027
    • Janjua, N.Z.1    Skowronski, D.M.2    Hottes, T.S.3    Osei, W.4    Adams, E.5    Petric, M.6    Sabaiduc, S.7    Chan, T.8    Mak, A.9    Lem, M.10
  • 44
    • 77958175225 scopus 로고    scopus 로고
    • Association between 2009 seasonal influenza vaccine and influenza-like illness during the 2009 pandemic: preliminary results of a large household transmission study in Western Australia
    • Available online:
    • Carcione DP, Giele C, Goggin LS, Kwan KS, Smith DW, Dowse GK, Mak DB, Effler P. Association between 2009 seasonal influenza vaccine and influenza-like illness during the 2009 pandemic: preliminary results of a large household transmission study in Western Australia. Euro Surveill 2010, 15(28):pii=19616. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19616.
    • (2010) Euro Surveill , vol.15 , Issue.28
    • Carcione, D.P.1    Giele, C.2    Goggin, L.S.3    Kwan, K.S.4    Smith, D.W.5    Dowse, G.K.6    Mak, D.B.7    Effler, P.8
  • 45
    • 72049100100 scopus 로고    scopus 로고
    • Notes from the field: outbreak of 2009 pandemic influenza a (H1N1) virus at a large public university in Delaware, April-May 2009
    • 10.1086/649555, 19911964
    • Iuliano AD, Reed C, Guh A, Desai M, Dee DL, Kutty P, Gould LH, Sotir M, Grant G, Lynch M, et al. Notes from the field: outbreak of 2009 pandemic influenza a (H1N1) virus at a large public university in Delaware, April-May 2009. Clin Infect Dis 2009, 49:1811-1820. 10.1086/649555, 19911964.
    • (2009) Clin Infect Dis , vol.49 , pp. 1811-1820
    • Iuliano, A.D.1    Reed, C.2    Guh, A.3    Desai, M.4    Dee, D.L.5    Kutty, P.6    Gould, L.H.7    Sotir, M.8    Grant, G.9    Lynch, M.10
  • 46
    • 80051565078 scopus 로고    scopus 로고
    • Pandemic influenza H1N1 2009 infection in Victoria, Australia: no evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009
    • 10.1016/j.vaccine.2011.03.055, 21473950
    • Kelly HA, Grant KA, Fielding JE, Carville KS, Looker CO, Tran T, Jacoby P. Pandemic influenza H1N1 2009 infection in Victoria, Australia: no evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009. Vaccine 2011, 29:6419-6426. 10.1016/j.vaccine.2011.03.055, 21473950.
    • (2011) Vaccine , vol.29 , pp. 6419-6426
    • Kelly, H.A.1    Grant, K.A.2    Fielding, J.E.3    Carville, K.S.4    Looker, C.O.5    Tran, T.6    Jacoby, P.7
  • 47
    • 79952222329 scopus 로고    scopus 로고
    • No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England
    • 10.1016/j.vaccine.2011.01.046, 21292008
    • Pebody R, Andrews N, Waight P, Malkani R, McCartney C, Ellis J, Miller E. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England. Vaccine 2011, 29:2613-2618. 10.1016/j.vaccine.2011.01.046, 21292008.
    • (2011) Vaccine , vol.29 , pp. 2613-2618
    • Pebody, R.1    Andrews, N.2    Waight, P.3    Malkani, R.4    McCartney, C.5    Ellis, J.6    Miller, E.7
  • 50
    • 78649898141 scopus 로고    scopus 로고
    • How did the 2008-2009 seasonal influenza vaccine affect the pandemic?
    • 10.1086/657312, 21067354
    • Glezen WP. How did the 2008-2009 seasonal influenza vaccine affect the pandemic?. Clin Infect Dis 2010, 51:1380-1382. 10.1086/657312, 21067354.
    • (2010) Clin Infect Dis , vol.51 , pp. 1380-1382
    • Glezen, W.P.1
  • 51
    • 78649768784 scopus 로고    scopus 로고
    • Seasonal influenza vaccination and the risk of infection with pandemic influenza: a possible illustration of non-specific temporary immunity following infection
    • Available online:
    • Kelly H, Barry S, Laurie K, Mercer G. Seasonal influenza vaccination and the risk of infection with pandemic influenza: a possible illustration of non-specific temporary immunity following infection. Euro Surveill 2010, 15(47):pii=19722. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19722.
    • (2010) Euro Surveill , vol.15 , Issue.47
    • Kelly, H.1    Barry, S.2    Laurie, K.3    Mercer, G.4
  • 52
    • 79953760751 scopus 로고    scopus 로고
    • Seasonal influenza vaccination and the 2009 pandemic
    • 10.1093/cid/cir035, 21367738
    • Mercer G, Kelly H. Seasonal influenza vaccination and the 2009 pandemic. Clin Infect Dis 2011, 52:828-829. 10.1093/cid/cir035, 21367738.
    • (2011) Clin Infect Dis , vol.52 , pp. 828-829
    • Mercer, G.1    Kelly, H.2
  • 53
    • 79954441457 scopus 로고    scopus 로고
    • Epidemiologischer Steckbrief der pandemischen Influenza (H1N1) 2009 basierend auf Einzelfallmeldungen nach Infektionsschutzgesetz
    • Buda S, Köpke K, Haas W. Epidemiologischer Steckbrief der pandemischen Influenza (H1N1) 2009 basierend auf Einzelfallmeldungen nach Infektionsschutzgesetz. Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 2010, 53:1223-1230.
    • (2010) Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz , vol.53 , pp. 1223-1230
    • Buda, S.1    Köpke, K.2    Haas, W.3
  • 55
    • 77951863381 scopus 로고    scopus 로고
    • Morbid Obesity as a Risk Factor for Hospitalization and Death Due to 2009 Pandemic Influenza A(H1N1) Disease
    • 10.1371/journal.pone.0009694, 2837749, 20300571
    • Morgan OW, Bramley A, Fowlkes A, Freedman DS, Taylor TH, Gargiullo P, Belay B, Jain S, Cox C, Kamimoto L, et al. Morbid Obesity as a Risk Factor for Hospitalization and Death Due to 2009 Pandemic Influenza A(H1N1) Disease. PLoS One 2010, 5:e9694. 10.1371/journal.pone.0009694, 2837749, 20300571.
    • (2010) PLoS One , vol.5
    • Morgan, O.W.1    Bramley, A.2    Fowlkes, A.3    Freedman, D.S.4    Taylor, T.H.5    Gargiullo, P.6    Belay, B.7    Jain, S.8    Cox, C.9    Kamimoto, L.10
  • 56
    • 79951817561 scopus 로고    scopus 로고
    • A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1)
    • 12, 3060888, 21148512, the CP
    • Louie JK, Acosta M, Samuel MC, Schechter R, Vugia DJ, Harriman K, Matyas BT, . the CP A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis 2011, 52:1. 12, 3060888, 21148512, the CP.
    • (2011) Clin Infect Dis , vol.52 , pp. 1
    • Louie, J.K.1    Acosta, M.2    Samuel, M.C.3    Schechter, R.4    Vugia, D.J.5    Harriman, K.6    Matyas, B.T.7
  • 57
    • 27744480659 scopus 로고    scopus 로고
    • Respiratory Tract Infections: another reason not to smoke
    • 10.3949/ccjm.72.10.916, 16231688
    • Murin S, Bilello KS. Respiratory Tract Infections: another reason not to smoke. Cleve Clin J Med 2005, 72:916-920. 10.3949/ccjm.72.10.916, 16231688.
    • (2005) Cleve Clin J Med , vol.72 , pp. 916-920
    • Murin, S.1    Bilello, K.S.2
  • 59
    • 45249100642 scopus 로고    scopus 로고
    • Pediatric population size is associated with geographic patterns of Acute Respiratory Infections among adults
    • 10.1016/j.annemergmed.2008.02.009, 2597284, 18374453
    • Brownstein JS, Mandl KD. Pediatric population size is associated with geographic patterns of Acute Respiratory Infections among adults. Ann Emerg Med 2008, 52:63-68. 10.1016/j.annemergmed.2008.02.009, 2597284, 18374453.
    • (2008) Ann Emerg Med , vol.52 , pp. 63-68
    • Brownstein, J.S.1    Mandl, K.D.2
  • 60
    • 26444527353 scopus 로고    scopus 로고
    • Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system
    • 10.1093/aje/kwi257, 1266301, 16107568
    • Brownstein JS, Kleinman KP, Mandl KD. Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system. Am J Epidemiol 2005, 162:686-693. 10.1093/aje/kwi257, 1266301, 16107568.
    • (2005) Am J Epidemiol , vol.162 , pp. 686-693
    • Brownstein, J.S.1    Kleinman, K.P.2    Mandl, K.D.3
  • 61
    • 0037468681 scopus 로고    scopus 로고
    • How contagious are common respiratory tract infections?
    • 10.1056/NEJMra021771, 12660390
    • Musher DM. How contagious are common respiratory tract infections?. N Engl J Med 2003, 348:1256-1266. 10.1056/NEJMra021771, 12660390.
    • (2003) N Engl J Med , vol.348 , pp. 1256-1266
    • Musher, D.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.